Donato Pezzulla

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 07, 2026

Reconsidering PARP inhibitor-radiotherapy combinations in the stereotactic era.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 03, 2026

Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.

Journal: The Lancet. Oncology

Published: March 04, 2026

Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 11, 2026

Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.

Journal: Radiation oncology (London, England)

Published: December 19, 2025

Stereotactic body radiation therapy (SBRT) with MRI-Linac in oligometastatic gynaecological cancer patients: a systematic review.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 16, 2025

Does Curative Radiotherapy Impact Fatigue Onset in Prostate Cancer Patients? An Analysis of 1253 Patients.

Journal: Cancer reports (Hoboken, N.J.)

Published: September 26, 2025

Reassessing the risks: toxicity of stereotactic ablative radiotherapy after bevacizumab in oligometastatic ovarian cancer-a new perspective for radiation oncologists?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 18, 2025

Accelerated Radiotherapy for Complicated Bone Metastases: SHARON Bone Randomized Phase III Trial Shows Non-Inferiority Compared to Standard Palliative Fractionation (NCT03503682).

Journal: Cancers

Published: April 13, 2025

Comment on: Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials.

Journal: Therapeutic advances in medical oncology

Published: February 26, 2025

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Reconsidering PARP inhibitor-radiotherapy combinations in the stereotactic era.

Reconsidering PARP inhibitor-radiotherapy combinations in the stereotactic era.

Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.

Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.

Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancer.

Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancer.

Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.

Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.

Stereotactic body radiation therapy (SBRT) with MRI-Linac in oligometastatic gynaecological cancer patients: a systematic review.

Stereotactic body radiation therapy (SBRT) with MRI-Linac in oligometastatic gynaecological cancer patients: a systematic review.

Does Curative Radiotherapy Impact Fatigue Onset in Prostate Cancer Patients? An Analysis of 1253 Patients.

Does Curative Radiotherapy Impact Fatigue Onset in Prostate Cancer Patients? An Analysis of 1253 Patients.

Reassessing the risks: toxicity of stereotactic ablative radiotherapy after bevacizumab in oligometastatic ovarian cancer-a new perspective for radiation oncologists?

Reassessing the risks: toxicity of stereotactic ablative radiotherapy after bevacizumab in oligometastatic ovarian cancer-a new perspective for radiation oncologists?

Predictive factors of response in lung metastases treated by sbrt from colon rectal cancer.

Predictive factors of response in lung metastases treated by sbrt from colon rectal cancer.

Managing unplanned radiotherapy interruptions in Italy: results from an AIRO survey.

Managing unplanned radiotherapy interruptions in Italy: results from an AIRO survey.

Accelerated Radiotherapy for Complicated Bone Metastases: SHARON Bone Randomized Phase III Trial Shows Non-Inferiority Compared to Standard Palliative Fractionation (NCT03503682).

Accelerated Radiotherapy for Complicated Bone Metastases: SHARON Bone Randomized Phase III Trial Shows Non-Inferiority Compared to Standard Palliative Fractionation (NCT03503682).

Comment on: Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials.

Comment on: Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials.